Evaluation of urine biomarkers of kidney injury in polycystic kidney disease
Open Access
- 1 April 2012
- journal article
- Published by Elsevier in Kidney International
- Vol. 81 (8) , 784-790
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Evidence of Extraordinary Growth in the Progressive Enlargement of Renal CystsClinical Journal of the American Society of Nephrology, 2010
- Molecular Advances in Autosomal Dominant Polycystic Kidney DiseaseAdvances in Chronic Kidney Disease, 2010
- Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney diseaseKidney International, 2009
- Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)Nephrology Dialysis Transplantation, 2009
- Primary Cilia and Signaling Pathways in Mammalian Development, Health and DiseaseNephron Physiology, 2009
- A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1Nature Medicine, 2007
- Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD studyBMC Nephrology, 2007
- Caspases and calpain are independent mediators of cisplatin-induced endothelial cell necrosisAmerican Journal of Physiology-Renal Physiology, 2006
- Volume Progression in Polycystic Kidney DiseaseNew England Journal of Medicine, 2006
- New insights into ADPKD molecular pathways using combination of SAGE and microarray technologiesGenomics, 2004